Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients

Haemodialysis patients respond poorly to vaccination and continue to be at-risk for severe COVID-19. Therefore, dialysis patients were among the first for which a fourth COVID-19 vaccination was recommended. However, targeted information on how to best maintain immune protection after SARS-CoV-2 vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Matthias, Cossmann, Anne, Lürken, Karsten, Junker, Daniel, Gruber, Jens, Juengling, Jennifer, Ramos, Gema Morillas, Beigel, Andrea, Wrenger, Eike, Lonnemann, Gerhard, Stankov, Metodi V., Dopfer-Jablonka, Alexandra, Kaiser, Philipp D., Traenkle, Bjoern, Rothbauer, Ulrich, Krause, Gérard, Schneiderhan-Marra, Nicole, Strengert, Monika, Dulovic, Alex, Behrens, Georg M. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582343/
https://www.ncbi.nlm.nih.gov/pubmed/36275672
http://dx.doi.org/10.3389/fimmu.2022.1004045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582343/
https://www.ncbi.nlm.nih.gov/pubmed/36275672
http://dx.doi.org/10.3389/fimmu.2022.1004045

Ejemplares similares